Evidence map›Paper›PMID 31561459›Full record

ReviewInternational journal of molecular sciences2019

More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.

Kerry B Goralski, Ashley E Jackson, Brendan T McKeown, Christopher J Sinal

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kerry B GoralskiCollege of Pharmacy, Faculty of Health, Dalhousie University, Halifax, NS B3H 4R2, Canada. Kerry.Goralski@Dal.Ca.
Ashley E JacksonDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. a.jackson13@dal.ca.ORCID 0000-0002-7290-3343
Brendan T McKeownDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. Brendan.McKeown@Dal.Ca.
Christopher J SinalDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. Christopher.Sinal@dal.ca.
Dalhousie University · CA

Funding

CIHR MOP15
6 · The paper itself

Abstract

Chemerin is widely recognized as an adipokine, with diverse biological roles in cellular differentiation and metabolism, as well as a leukocyte chemoattractant. Research investigating the role of chemerin in the obesity-cancer relationship has provided evidence both for pro- and anti-cancer effects. The tumor-promoting effects of chemerin primarily involve direct effects on migration, invasion, and metastasis as well as growth and proliferation of cancer cells. Chemerin can also promote tumor growth via the recruitment of tumor-supporting mesenchymal stromal cells and stimulation of angiogenesis pathways in endothelial cells. In contrast, the majority of evidence supports that the tumor-suppressing effects of chemerin are immune-mediated and result in a shift from immunosuppressive to immunogenic cell populations within the tumor microenvironment. Systemic chemerin and chemerin produced within the tumor microenvironment may contribute to these effects via signaling through CMKLR1 (chemerin

Indexed as

Signal TransductionAdipokinesAnimalsBiomarkersChemokinesDisease SusceptibilityHumansImmunomodulationNeoplasmsObesityOrgan SpecificityProtein BindingAdipokinesBiomarkersChemokinesRARRES2 protein, humanadipokinecancerC-C chemokine receptor-like 2chemerinchemokine-like receptor 1G protein-coupled receptor 1obesity

Identifiers

PMID31561459
PMCPMC6801800
OpenAlexW2975383676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.